DCVAC/OvCa

· SOTIO a.s.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for DCVAC/OvCa, covering 2016-11-30 to 2022-05-04. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Study DCVAC/OvCa Added to First Line Carboplatin and Paclitaxel Newly Diagnosed Epithelial Ovarian Carcinoma [Phase 2]

See pricing